Nothing Special   »   [go: up one dir, main page]

Test Report: Pass. No.

Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

TEST REPORT

Reg. No. : 1058802574 Reg. Date : 24-May-2021 02:28 Ref.No : Collected On : 24-May-2021 02:28
Name : YALAMANCHILI LAKSHMI Reported Date : 24-May-2021
Age : 56 Years Gender : Female Pass. No. : Dispatch At :
Ref. By : Tele No. :
Location :

Test Name Results Units Bio. Ref. Interval


MOLECULAR ANALYSIS FOR QUALITATIVE DETECTION OF SARS-CoV-2.
Type of sample : Nasopharyngeal swab and Oropharyngeal swab.
Methodology : Real time PCR. ICMR NO :UNIPA001
ORF 1ab Positive [CT Value: 17 ]
N Gene Positive [CT Value: 19 ]
Internal Control Pass
Interpretation
2019-nCoV POSITIVE

Note:-
For results with S-Gene negative and other two genes positive: These samples may have 69-70del S gene mutation
which is usually associated with, but not limited to B.1.1.7 variant (UK VOC-202012/01). Since our assay is designed
to detect multiple genetic targets (ORF and N genes along with S gene), the overall test sensitivity is not impacted by
this variant. (Ref: https://www.fda.gov/medical-devices/letters-health-care-providers/genetic-variants-sars-cov-2-may-
lead-false-negative-results-molecular-tests-detection-sars-cov-2)
1 - Test report should be correlated with the clinical presentation and findings.
2 - The LOD for the three target genes is 10 copies/reaction.
3 - A negative result does not rule out 2019-nCoV and should not be used as the sole basis for treatment or other
patient management decisions.
4 - A number of factors could lead to a negative result in an infected individual including 1) Poor quality of the
specimen, containing nadequate patient material or non-representative specimen 2) The specimen was collected late
or very early in the infection.Optimum specimen types and timing for peak viral levels during infections caused by
2019-nCoV have not been determined.Collection of multiple samples from the same patient may be necessary to
detect the virus 3) The specimen was not handled and shipped appropriately 4) Technical reasons inherent in the test
(like Virus mutation or PCR inhibition) 5) Inadequate numbers of organisms are present in the specimen
5 - Reports will be provided to the treating physician, who is requested to communicate the same to the patient and
follow MOHFW policy for isolation, quarantine and treatment of all positive cases along with contact tracing as
recommended.
6 - Repeat sampling and testing of lower respiratory specimen is strongly recommended in severe or progressive
disease.
7 - The repeat specimens may be considered after a gap of 2-4 days after the collection of the first specimen for
additional testing if required.
8 - Categories of viral load is based on Cycle threshold (Ct) detected by RT PCR.
9 - High viral load: up to 23; Moderate viral load: 24 to 31; Low/Mild viral load: 32 to 35

------------------ End Of Report ------------------

Test done from collected sample. This is an electronically authenticated report.

Approved by: Dr. Ekta Jajodia


M.D (Path.),
Generated On : 24-May-2021 22:24 PDF (Molecular
Approved On: 24-May-2021 Hematology,
10:52
CMC, Vellore),
Page 1 of 1
Consultant Pathologist

You might also like